AzTrials
AzTrials

Enteral NutritionNCT04601571

Confirming Feeding Tube Position Using CORTRAK

A study testing CORTRAK Stylet in people with Enteral Nutrition, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This study will compare the accuracy of the CORTRAK enteral access system (CEAS) to x-ray for the determination of feeding tube position within the abdomen. Read more about this study

Who is it for?
Ages Up to 17 years
Conditions the study is for
Enteral Nutrition
What is being tested?
CORTRAK Stylet
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
Mar 2024to Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • CORTRAK feeding tube placed as part of clinical care
  • Getting xray for any reason
  • CORTRAK Stylet available in the room
  • Pediatric patients (Aged 17 or younger)

Who cannot join

  • -CORTRAK Stylet has been misplaced

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University Health Systems Hospital

    San Antonio, Texas, 78229

Other trials in United States

About this study

Official title: Confirming Feeding Tube Position Using the CORTRAK Enteral Access System

This study will compare the accuracy of the CORTRAK enteral access system (CEAS) to x-ray for the determination of feeding tube position within the abdomen.

Read the detailed description

In the inpatient pediatric care area (PICU, PCCU, PIMU, ACU), when an x-ray is performed for any reason and a patient has a CORTRAK feeding tube, a provider from the research team will re-insert the small, individualized, flexible stylet back into the patient's feeding tube and document the position of the tube on the CORTRAK display monitor. The x-ray will be obtained by current standard of care and the tube location on x-ray will be compared to the tube location on the CORTRAK monitor. The x-ray will only be obtained as part of the routine care decided by the medical team, the patient will not receive any additional x-rays for this study.

Being tested
CORTRAK Stylet

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CORTRAK StyletDevice

    Also called Feeding tube stylet

    The stylet is a component of the CORTRAK feeding tube system used to confirm the correct placement of the feeding tube

Study groups in NCT04601571
Study groupRoleWhat they receive
Feeding Tube Placement using CORTRAK styletActive comparatorSubjects will already have a feeding tube placed and are undergoing X-rays for placement confirmation.
Receives: Device: CORTRAK Stylet
Feeding Tube Placement using X-RayNo interventionRoutine X-ray is used to confirm feeding tube placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Confirmation of correct placement of the Feeding tube

    An x-ray will be obtained first as per standard of care and within 4 hours of the x-ray, the research procedure will occur. Following slow and careful removal of the stylet, the research team member will ensure there has been no movement of the feeding tube per the depth indicators on the outside of the tube. The location of the tube as it appears on the CORTRAK monitor will be documented and the location of the tube on x-ray will be documented. This will be reported as number of times that the tube is correctly placed.

    Measured: Baseline to removal of feeding tube (on average 10-14 days)

Secondary outcomes (1)
  1. Number of Radiographs required for placement

    Count of radiographs used to ensure correct placement of enteral feeding tube

    Measured: Baseline to removal of feeding tube (on average 10-14 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2020
  2. Study startMar 2024 (estimated)
  3. Primary completionJun 2025 (estimated)
  4. Study completionJun 2026 (estimated)

Why it stopped: Despite the study being in active enrollment since 2020, the research staff has not been available to enroll patients because of lack of trained nursing staff.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
A non-inferior cohort study design
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04601571
Sponsor's protocol ID
HSC20200625H
Status last verified
May 2024
First submitted
19 Oct 2020
Last updated
8 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing CORTRAK Stylet in people with Enteral Nutrition, run by The University of Texas Health Science Center at San Antonio at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 8 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Confirmation of correct placement of the Feeding tube (time frame: Baseline to removal of feeding tube (on average 10-14 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in